• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Metabolites . Lactate Kinetics Reflect Organ Dysfunction and Are Associated with Adverse Outcomes in Intensive Care Unit Patients with COVID-19 Pne

tetano

Editor, Senior Moderator
Metabolites


. 2020 Sep 28;10(10):E386.
doi: 10.3390/metabo10100386.
Lactate Kinetics Reflect Organ Dysfunction and Are Associated with Adverse Outcomes in Intensive Care Unit Patients with COVID-19 Pneumonia: Preliminary Results from a GREEK Single-Centre Study


Alice G Vassiliou[SUP] 1 [/SUP], Edison Jahaj[SUP] 1 [/SUP], Ioannis Ilias[SUP] 1 [/SUP], Vassiliki Markaki[SUP] 1 [/SUP], Sotirios Malachias[SUP] 1 [/SUP], Charikleia Vrettou[SUP] 1 [/SUP], Eleni Ischaki[SUP] 1 [/SUP], Zafeiria Mastora[SUP] 1 [/SUP], Evangelia Douka[SUP] 1 [/SUP], Chrysi Keskinidou[SUP] 1 [/SUP], Stamatios Tsipilis[SUP] 1 [/SUP], Dimitra A Vassiliadi[SUP] 1 [/SUP], Anastasia Kotanidou[SUP] 1 [/SUP], Ioanna Dimopoulou[SUP] 1 [/SUP]



Affiliations

Abstract

Coronavirus disease-19 (COVID-19) continues to be a health threat worldwide. Increased blood lactate is common in intensive care unit (ICU) patients; however, its association with outcomes in ICU COVID-19 patients remains currently unexplored. In this retrospective, observational study we assessed whether lactate is associated with outcomes in COVID-19 patients. Blood lactate was measured on ICU admission and thereafter daily up to day 14 in 45 patients with confirmed COVID-19 pneumonia. Acute physiology and chronic health evaluation (APACHE II) was calculated on ICU admission, and sequential organ failure assessment (SOFA) score was assessed on admission and every second day. The cohort was divided into survivors and non-survivors based on 28-day ICU mortality (24.4%). Cox regression analysis revealed that maximum lactate on admission was independently related to 28-day ICU mortality with time in the presence of APACHE II (RR = 2.45, p = 0.008). Lactate's area under the curve for detecting 28-day ICU mortality was 0.77 (p = 0.008). Mixed model analysis showed that mean daily lactate levels were higher in non-survivors (p < 0.0001); the model applied on SOFA scores showed a similar time pattern. Thus, initial blood lactate was an independent outcome predictor in COVID-19 ICU patients. The time course of lactate mirrors organ dysfunction and is associated with poor clinical outcomes.

Keywords: COVID-19; SOFA; acute respiratory distress syndrome; lactate; mortality.
 
Back
Top Bottom